Internal Medicine &amp; Geriatrics

1/05/20 → 30/04/23

Project: Research

AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With

Johnson, L. (PI) & Davis, S. (CoI)

1/01/20 → 31/12/24

Project: Research

The A45 Study: Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease

Johnson, L. (PI) & Davis, S. (CoI)

30/09/19 → 31/05/21

Project: Research

Geriatric Academic Career Award (GACA)

Camp, K. (PI)

1/09/19 → 31/08/23

Project: Research

Workforce Enhancement in Healthy Aging and Independent Living

Knebl, J. (PI) & Ross, S. (CoI)

1/07/19 → 30/06/24

Project: Research

Workforce Enhancement in Healthy Aging and Independent Living

Knebl, J. (PI)

1/07/19 → 30/06/24

Project: Research

Geriatrics Workforce Enhancement Program - Supplement

Knebl, J. (PI) & Ross, S. (CoI)

1/07/19 → 30/06/24

Project: Research

Workforce Enhancement in Healthy Aging and Independent Living

Knebl, J. (PI), Harty, B. (CoI) & Ross, S. (CoI)

1/07/19 → 30/06/24

Project: Research

Workforce Enhancement in Healthy Aging and Independent Living

Knebl, J. (PI), Fairchild, T. (CoI), Severance, J. (CoI), Camp, K. (CoI), Hadley, L. (CoI) & Agena, V. (CoI)

United Way of Tarrant County

1/07/19 → 30/06/24

Project: Research

Collective Action to Drive Systems-Level Change

Severance, J. (PI) & Knebl, J. (CoI)

1/07/19 → 30/06/20

Project: Research

Workforce Enhancement in Healthy Aging and Independent Living

Knebl, J. (PI), Severance, J. (CoI), Love, B. (CoI), Murphy, S. (CoI), Camp, K. (CoI) & Hadley, L. (CoI)

1/07/19 → 30/06/24

Project: Research

The A3 Study: Ante-Amyloid Pre

Johnson, L. (PI), Large, S. (CoI) & Davis, S. (CoI)

Roche Diagnostics Corporation

1/06/19 → 30/04/24

Project: Research

BN4003 l Version 2, entitled "A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE ill STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER'S DISEASE

Knebl, J. (PI)

30/11/18 → 30/11/21

Project: Research

Detection of Elder Abuse Through Emergency Care Technicians (DETECT)

O'Bryant, S. (PI), Zhang, F. (CoI) & Davis, S. (CoI)

University of Texas HSC at Houston

15/09/18 → 31/05/23

Project: Research

Assessing the Utility and Effectiveness of Dementia Patient Monitoring Technology

Reuter, K. (PI) & Knebl, J. (CoI)

Texas A&M Health Science Center

22/08/18 → 31/08/20

Project: Research

Collective Action to Drive Systems-Level Change

Severance, J. (PI) & Knebl, J. (CoI)

United Way of Tarrant County

1/07/18 → 30/06/19

Project: Research

ALZHEIMER¿S DISEASE- DONEPEZIL HYDROCHLORIDE AND MEMANTINE HYDROCHLORIDE

Knebl, J. (PI)

Merck Co.

31/05/18 → 31/05/21

Project: Research

HRSA GWEP Small Networking Meetings

Knebl, J. (PI) & Severance, J. (CoI)

American Geriatrics Society

1/09/17 → 31/12/17

Project: Research

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).

Kline, G. (PI)

Boehringer Ingelheim International GmbH

25/04/17 → 24/04/21

Project: Research

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

Kline, G. (PI)

Boehringer Ingelheim International GmbH

25/04/17 → 24/04/21

Project: Research

PROMINENT- PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES

Kline, G. (PI)

Kowa Research Institute, Inc.

31/03/17 → 31/03/21

Project: Research

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (ETC-I 002) on the Occurrence of Major Cardiovascular Events in Patients with, or at High Risk For,Cardiovascular Disease Who Are Statin Intolerant

Kline, G. (PI)

Esperion Therapeutics, Inc.

13/02/17 → 13/02/21

Project: Research

An Interprofessional Approach to Patient Safety Improvement in Skilled Nursing Facilities

Ross, S. (PI)

Intramural Research(UNTHSC)

1/01/17 → 30/06/18

Project: Research

Opportunities for Peer Models of Health Promotion in Senior Centers: An Exploratory Study

Severance, J. (PI)

Intramural Research(UNTHSC)

1/01/17 → 31/12/17

Project: Research

A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia (The DAYBREAK Study)

Knebl, J. (PI)

Eli Lilly

13/10/16 → 12/10/21

Project: Research

"A PHASE Ill, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER'S DISEASE"

Knebl, J. (PI)

Hoffmann-La Roche Inc.

18/08/16 → 17/08/21

Project: Research

Workforce Enhancement Healthy Aging and Independent Living (WE HAIL)

Knebl, J. (PI), Fairchild, T. (CoI), Severance, J. (CoI), Fulda, K. (CoI), Ross, S. (CoI) & Bugnariu, N. (CoI)

1/07/15 → 30/06/19

Project: Research

Opioid Supplement

Knebl, J. (PI)

1/07/15 → 30/06/19

Project: Research

Workforce Enhancement Healthy Aging and Independent Living (WE HAIL)

Knebl, J. (PI) & Ross, S. (CoI)

1/07/15 → 30/06/19

Project: Research

A Long-term Outcomes Study to Assess Statin Residual Risk Reduction with EpaNova High Cardiovascular Risk Patients witgh Hypertriglyceridemia (STRENGTH)

Kline, G. (PI)

Astra Zeneca

8/06/15 → 30/06/24

Project: Research

An open-label extension study to evaluate the long-term safety and tolerability of Lu AE58054 as adjunctive treatment to donepezil in patients with mild-moderate Alzheimer¿s disease

Knebl, J. (PI)

Lundbeck Pharmaceuticals

3/04/15 → 30/04/20

Project: Research

A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Long-term Safety and Tolerability of PF-04950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipdemia at Risk of Cardiovascular Events

Kline, G. (PI)

Pfizer, Inc.

17/03/15 → 31/03/20

Project: Research

Randomized, Double-blind, Parallel Group, Placebo-controlled, Fixed-dose of Lu AE58054 In Patients with Mild - Moderate Alzheimer's Disease Treated with Donepazil; Study 2

Knebl, J. (PI)

Lundbeck Pharmaceuticals

8/12/14 → 31/12/19

Project: Research

A Phase II, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Efficacy and Safety of RO4602522 Added to Background Alzheimer¿s Disease Therapy in Patients with Moderate Severity Alzheimer¿s Disease

Knebl, J. (PI)

Hoffmann-La Roche Inc.

25/10/13 → 31/03/19

Project: Research

Tuberculosis Trials Consortium

Weis, S. (PI)

Intramural Research(UNTHSC)

18/09/13 → 17/09/14

Project: Research

Discharge Planning and Care Coordinated with Medicaid Eligible Elders with TCOM Student Danielle Ortega

Knebl, J. (PI)

1/09/13 → 31/08/14

Project: Research

Reynolds Interprofessional Geriatrics Education and Training in Texas (/GET-IT) Program

Knebl, J. (PI)

Donald W. Reynolds Foundation

1/07/13 → 30/06/17

Project: Research

Discharge Planning and Care Coordination for Medicaid Eligible Elders

Knebl, J. (PI), Bugnariu, N. (CoI) & O'Bryant, S. (CoI)

Centers for Medicare & Medicaid Services

1/06/13 → 31/12/17

Project: Research

A Readomized. Double-blind, Placebo-controlled,Parallel-group Studfy to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patgients Who Have Recently Experienced an Acute Coronary Syndrome

Kline, G. (PI)

Sanofi Pasteur, Inc.

31/01/13 → 30/01/20

Project: Research

Tuberculosis Trials Consortium

Weis, S. (PI)

Baylor College of Medicine

18/09/12 → 17/09/13

Project: Research

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E ¿4 Non-Carriers

Knebl, J. (PI)

Pfizer, Inc.

14/11/11 → 30/11/15

Project: Research

The Texas Consortium Geriatrics Education Center

Knebl, J. (PI)

1/07/10 → 30/06/15

Project: Research

A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (ABB-001, ELN115727) in Subjects with Alzheimer's Disease who Participated in Study ELN115727-301 or in Study ELN115727-302

Knebl, J. (PI)

Janssen Pharmaceuticals

4/05/10 → 31/12/13

Project: Research

Tuberculosis Trials Consortium

Weis, S. (PI)

18/09/09 → 17/09/19

Project: Research

Task Order #30 Quantifying The Risk Of Premature Death In TB Survivors

Weis, S. (PI) & Miller, T. (CoI)

15/09/09 → 14/09/11

Project: Research

Task Order # 32 Quantifying The Risk Of Premature Death in TB Survivors

Weis, S. (PI) & Miller, T. (CoI)